Primary hyperoxaluria (PH) is a rare autosomal genetic form of Hyperoxaluria, a condition that leads to the excessive urinary excretion of oxalate. Till now, three distinct hereditary enzymatic def...
Nevro Received FDA Approval of its 10 kHz High-Frequency Spinal Cord Stimulation Therapy for Treatment of Chronic Pain Associated with Painful Diabetic Neuropathy On July 19, 2021, Nevro Corp. received approval for its Senza System, Nevro's unique 10 kHz stimulation, to treat chronic pain associated with Painful...
Find More
BlueRock Therapeutics secures FDA fast track for Parkinson’s disease cell therapy BlueRock, a Bayer subsidiary, is currently assessing the pluripotent stem cell-derived dopaminergic neuron therapy in a phase 1 study. This early-stage trial is set to enroll ten patients across the US and Canada, with its prima...
Find More
Insulin is a hormone secreted by the beta cells of the islets of langerhans in the pancreas. The hormone is responsible for the maintenance of normal blood glucose levels by facilitating cellular glucose uptake and regulating carbohydrate, protein, and lipid metabolism. Inappropriate functioning of insulin due to d...
Find More
LivaNova Secures FDA Approval for Clinical Study to Assess the aura6000 System for Obstructive Sleep Apnea Treatment On June 15, 2021, LivaNova PLC received approval from the US Food and Drug Administration (FDA) to continue with its investigational device exemption (IDE) clinical study, “Treating Ob...
Find More
A New Dawn for CRISPR, Intellia Edits Cells Inside the Body Intellia Therapeutics, along with its partner Regeneron Pharmaceuticals, recently announced its successful attempt in editing the cells inside the body leveraging the CRISPR technique. The world’s first-ever trial that has their DNA edited through an in...
Find More
Diabetes is a condition in which the blood glucose (blood sugar) level is abnormally high. Glucose, which is obtained from the food consumed, is the primary source of energy in the body. However, the excess glucose level in the blood can cause health issues over time and can lead to vision disorders like Diabetic R...
Find More
Neuropathy is the most usual complication that occurs due to diabetes, affecting up to about 50% of the patients. Painful diabetic neuropathy tends to take place in ~25% of the patients suffering from diabetes mellitus. These patients get treated in office settings, and it affects their quality of life. It also occ...
Find More
Diabetes today is a significant health issue for many countries worldwide. As per the WHO, “the number of people with diabetes rose from 108 million in 1980 to 422 million in 2014. The increasing prevalence has been observed to rise more rapidly in low- and middle-income countries than in high-income countries”. Si...
Find More
Vertex leads in CRISPR Therapeutics partnership with USD 900 Million upfront Vertex has boosted a deal with CRISPR Therapeutics to USD 900 million upfront as the companies compete against bluebird bio to the market with a novel gene-editing therapy for sickle cell disease and beta-thalassemia called CTX001. B...
Find More
With its innovative approach, chimeric antigen receptor T cell therapy created a new dawn in the age.....
Find More
Nestlé and Unilever are multinational corporations established in 1866 and 1930, respectively. The .....
Find More
Acromegaly is a rare, slowly progressive disorder that is caused when the pituitary glands produce t.....
Find More-Agonist.png)
Toll-like Receptors (TLRs) are a type of pattern recognition receptor (PRR) that recognizes pathogen.....
Find More
Vascular Dementia (VaD) is a common type of Dementia caused by reduced blood flow to the brain. VaD .....
Find More
Immunotherapies, a potentially life-saving therapy, have benefitted several patients suffering from .....
Find More-Agonist.png "Toll-like Receptors Agonist")
The American Society of Clinical Oncology (ASCO) is one of the largest and most respected conferences in the field of oncology. Held annually, this conference brings together researchers, physicians, and other healthcare professionals from around the world to discuss the latest advances in cancer research, diagnosis, and treatment.
